Literature DB >> 4598848

Nalidixic acid susceptibility testing of clinical isolates of Serratia marcescens.

J D Jollick, E M Schervish-Swierkosz, W J Brown.   

Abstract

Nalidixic acid (nal) susceptibility of clinical isolates of Serratia marcescens from urinary tract infections, wounds, and blood was determined by the standard disk method, and results were compared with results obtained by a standardized tube dilution procedure using five different broth media. An attempt was made to approximate in vivo conditions by using urine as a test medium and correlating the activity of nal in urine with its activity in nutrient, Trypticase soy, brain-heart infusion, and Mueller-Hinton broths. The isolates were consistently susceptible to lower concentrations of nal in nutrient broth than in the other media. The results showed that Mueller-Hinton broth most closely reflected nal activity in urine. A standardized procedure for nal susceptibility testing of urinary tract isolates of S. marcescens is proposed.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4598848      PMCID: PMC444590          DOI: 10.1128/AAC.4.5.532

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  Role of Serratia species in urinary tract infections.

Authors:  L J LANCASTER
Journal:  Arch Intern Med       Date:  1962-05

2.  Medium to aid identification of Serratia marcescens.

Authors:  R L Hamilton; W J Brown
Journal:  Am J Med Technol       Date:  1972-03

3.  Serratia marcescens. Biochemical characteristics, antibiotic susceptibility patterns, and clinical significance.

Authors:  C J Wilkowske; J A Washington; W J Martin; R E Ritts
Journal:  JAMA       Date:  1970-12-21       Impact factor: 56.272

4.  Microbiological properties of a new cephalosporin, BL-S 339: 7-(phenylacetimidoyl-aminoacetamido)-3-(2-methyl-1,3,4-thiadiazol-5-ylthiomethyl)ceph-3-em-4-carboxylic acid.

Authors:  M Misiek; T A Pursiano; F Leitner; K E Price
Journal:  Antimicrob Agents Chemother       Date:  1973-01       Impact factor: 5.191

5.  Antibiotic susceptibility of nonpigmented Serratia marcescens.

Authors:  G F Thornton; J A Cramer
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

6.  Serratia marcescens septicemia.

Authors:  W H Dodson
Journal:  Arch Intern Med       Date:  1968-02

7.  Contribution of R factors to the antibiotic resistance of hospital isolates of Serratia.

Authors:  A A Medeiros; T F O'Brien
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1968

8.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

9.  Serratia marcescens: biochemical, serological, and epidemiological characteristics and antibiotic susceptibility of strains isolated at Boston City Hospital.

Authors:  J N Wilfert; F F Barrett; W H Ewing; M Finland; E H Kass
Journal:  Appl Microbiol       Date:  1970-02

10.  Antibiotic susceptibilities of Serratia marcescens and Enterobacter liquefaciens.

Authors:  P Greenup; D J Blazevic
Journal:  Appl Microbiol       Date:  1971-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.